The endocannabinoid anandamide prevents TH17 programming of activated T lymphocytes while preserving TH1 responses - Kiprina, Anastasiia; Teichmann, Tom; Martín Giménez, Virna Margarita; Xu, Wenqing; Sailer, Fiona; Windbergs, Maike; Manucha, Walter; Weigert, Andreas; Brandes, Ralf P. (Frontiers in Pharmacology, 2024)